Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 11737
TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643161(US20240002372, Example 3 | trifluoroacetate | US20...)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643165(US20240002372, Example 6)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643168(US20240002372, Example 9)
Affinity DataIC50: 10nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643159(US20240002372, Example 1)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643161(US20240002372, Example 3 | trifluoroacetate | US20...)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643163(US20240002372, Example 4 | trifluoroacetate)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643164(US20240002372, Example 5)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643166(US20240002372, Example 7)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643167(US20240002372, Example 8)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643169(US20240002372, Example 10)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643170(US20240002372, Example 11)
Affinity DataIC50: 550nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent

TargetMuscarinic acetylcholine receptor M3(Human)
Rezubio Pharmaceuticals Co.

US Patent
LigandPNGBDBM643171(US20240002372, Example 12)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were prepared in DMSO (stock concentration: 1 mM) and 3×serially diluted (10 concentrations) in 384-LDV plate (Labcyte). Ninety nL of seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2024
Entry Details
Go to US Patent